Turnstone Biologics Corp (TSBX)
180 Life Sciences Corp. (ATNF)
New Form 8-K - 180 Life Sciences Corp. Filed: 2025-08-11 AccNo: 0001213900-25-074030 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item …
Simulations Plus Inc (SLP)
Securities Fraud Investigation Into Simulations Plus, Inc. (SLP) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Laboratory Corporation of America Holdings (LH)
Turnstone Biologics Corp (TSBX)
Avantor Inc. (AVTR)
Avantor, Inc. - Avantor® Reiterates Shareholder Value Creation Focus
Avantor Inc. (AVTR)
Avantor® Reiterates Shareholder Value Creation Focus
Viatris Inc (VTRS)
Viatris Announces Approval of First Generic Iron Sucrose Injection in the U.S.
Palatin Technologies Inc. (PTN)
Unity Biotechnology Inc (UBX)
BioCardia Inc. (BCDAW)
BioCardia Inc. (BCDAW)
Turnstone Biologics Corp (TSBX)
Artelo Biosciences Inc. (ARTLW)
Artelo Biosciences Receives Notice of Allowance from European Patent Office for the Patent Claims for the Intended Commercial Formulation of ART27.13